India Russia Turkey virus covid-19 RNA medicines India Russia Turkey

Indian drug company gets DCGI nod to manufacture Covid-19 medicine

Reading now: 209
www.livemint.com

pharmaceuticals firm based in India, Biophore India Pharmaceuticals has received a license from the Drug Controller General of India (DCGI) to manufacture Favipiravir.

The active pharmaceutical salt is an important part of the finished formulation to treat mild to moderate Covid-19 cases.Favipiravir is an antiviral agent that was initially discovered and developed because of its activity against another RNA (ribonucleic acid) virus, the influenza virus.The drug has also received acceptance in Russia and parts of middle east in order to fight against Covid-19.

Other than these regions, it is also in advanced stage trials in other parts of the world.The new drug also received approval for exports as well.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA